Medicare patients with advanced cancers will now have access to a more 21st century diagnostic: gene-sequencing tests to match them with the right drugs.
Medicare patients with advanced cancers will now have access to a more 21st century diagnostic: gene-sequencing tests to match them with the right drugs.
Whenever the FDA catches falsified data or unreported side effects, it issues a warning letter to document the bad research. That’s good. But a new study shows...